Cargando…
SARS-CoV-2, ¿Nuevo agente causal del síndrome de Guillain-Barré?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U. y SEMICYUC.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474917/ https://www.ncbi.nlm.nih.gov/pubmed/32994061 http://dx.doi.org/10.1016/j.medin.2020.08.009 |
| _version_ | 1783579416682561536 |
|---|---|
| author | Esteban Molina, A. Mata Martínez, M. Sánchez Chueca, P. Carrillo López, A. |
| author_facet | Esteban Molina, A. Mata Martínez, M. Sánchez Chueca, P. Carrillo López, A. |
| author_sort | Esteban Molina, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7474917 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier España, S.L.U. y SEMICYUC. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74749172020-09-08 SARS-CoV-2, ¿Nuevo agente causal del síndrome de Guillain-Barré? Esteban Molina, A. Mata Martínez, M. Sánchez Chueca, P. Carrillo López, A. Med Intensiva Carta al Editor Elsevier España, S.L.U. y SEMICYUC. 2022-02 2020-09-06 /pmc/articles/PMC7474917/ /pubmed/32994061 http://dx.doi.org/10.1016/j.medin.2020.08.009 Text en © 2020 Elsevier España, S.L.U. y SEMICYUC. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta al Editor Esteban Molina, A. Mata Martínez, M. Sánchez Chueca, P. Carrillo López, A. SARS-CoV-2, ¿Nuevo agente causal del síndrome de Guillain-Barré? |
| title | SARS-CoV-2, ¿Nuevo agente causal del síndrome de Guillain-Barré? |
| title_full | SARS-CoV-2, ¿Nuevo agente causal del síndrome de Guillain-Barré? |
| title_fullStr | SARS-CoV-2, ¿Nuevo agente causal del síndrome de Guillain-Barré? |
| title_full_unstemmed | SARS-CoV-2, ¿Nuevo agente causal del síndrome de Guillain-Barré? |
| title_short | SARS-CoV-2, ¿Nuevo agente causal del síndrome de Guillain-Barré? |
| title_sort | sars-cov-2, ¿nuevo agente causal del síndrome de guillain-barré? |
| topic | Carta al Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474917/ https://www.ncbi.nlm.nih.gov/pubmed/32994061 http://dx.doi.org/10.1016/j.medin.2020.08.009 |
| work_keys_str_mv | AT estebanmolinaa sarscov2nuevoagentecausaldelsindromedeguillainbarre AT matamartinezm sarscov2nuevoagentecausaldelsindromedeguillainbarre AT sanchezchuecap sarscov2nuevoagentecausaldelsindromedeguillainbarre AT carrillolopeza sarscov2nuevoagentecausaldelsindromedeguillainbarre |